ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Ono Pharmaceutical Co., Ltd. ?
1
High Management Efficiency with a high ROE of 12.49%
2
Company has very low debt and has enough cash to service the debt requirements
3
With a growth in Net Profit of 93.19%, the company declared Outstanding results in Dec 25
- The company has declared positive results in Jan 70 after 3 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at JPY 125,635 MM
- RAW MATERIAL COST(Y) Fallen by -12.23% (YoY)
- CASH AND EQV(HY) Highest at JPY 372,198 MM
4
With ROE of 6.41%, it has a very attractive valuation with a 0.97 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 47.85%, its profits have fallen by -62%
- At the current price, the company has a high dividend yield of 0
5
Majority shareholders : FIIs
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Ono Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Ono Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Ono Pharmaceutical Co., Ltd.
47.85%
0.41
26.47%
Japan Nikkei 225
40.96%
1.35
28.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.73%
EBIT Growth (5y)
-4.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.57
Tax Ratio
15.48%
Dividend Payout Ratio
75.08%
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
20.45%
ROE (avg)
12.49%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.97
EV to EBIT
10.81
EV to EBITDA
7.59
EV to Capital Employed
0.96
EV to Sales
1.41
PEG Ratio
NA
Dividend Yield
0.03%
ROCE (Latest)
8.91%
ROE (Latest)
6.41%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at JPY 125,635 MM
RAW MATERIAL COST(Y)
Fallen by -12.23% (YoY
CASH AND EQV(HY)
Highest at JPY 372,198 MM
NET SALES(Q)
Highest at JPY 139,900 MM
OPERATING PROFIT(Q)
Highest at JPY 47,551 MM
OPERATING PROFIT MARGIN(Q)
Highest at 33.99 %
PRE-TAX PROFIT(Q)
Highest at JPY 37,202 MM
NET PROFIT(Q)
Highest at JPY 28,861 MM
EPS(Q)
Highest at JPY 61.42
-1What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.14 times
Here's what is working for Ono Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at JPY 125,635 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (JPY MM)
Net Sales
Highest at JPY 139,900 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 47,551 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 33.99 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 37,202 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Pre-Tax Profit
At JPY 37,202 MM has Grown at 113.82%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY 28,861 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
Net Profit
At JPY 28,861 MM has Grown at 93.19%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 61.42
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Cash and Eqv
Highest at JPY 372,198 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -12.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at JPY 9,594 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Ono Pharmaceutical Co., Ltd.
Inventory Turnover Ratio
Lowest at 2.14 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
